Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation pathways in atherothrombosis.

Alexey V Khrenov1, Natalya M Ananyeva, John H Griffin

  • 1Department of Biochemistry, Holland Laboratory, American Red Cross, Rockville, Maryland 20855, USA.

Trends in Cardiovascular Medicine
|November 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the binding of skeletal muscle myosin to fibrin in trauma.

The journal of trauma and acute care surgery·2026
Same author

Activated Protein C and the Retina: From Physiology to Therapeutic Potential.

International journal of molecular sciences·2026
Same author

Correction: Activated protein C ameliorates diabetes-induced atherosclerosis by sustaining macrophage efferocytosis.

Cardiovascular diabetology·2026
Same author

Endothelial protein C receptor-mediated endogenous and therapeutic transport of activated protein C across the blood-retina barrier protects the retina.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Activated protein C ameliorates diabetes-induced atherosclerosis by sustaining macrophage efferocytosis.

Cardiovascular diabetology·2025
Same author

A Bivalent Protease-Activated Receptor-Derived Peptide Mimics Neuronal Anti-Apoptotic Activity of Activated Protein C.

Bioengineering (Basel, Switzerland)·2025

Atherosclerosis complications stem from thrombosis. Understanding blood coagulation pathways in atherosclerotic plaques is crucial for developing effective atherothrombosis treatments.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pathophysiology

Background:

  • Atherosclerosis is a leading cause of mortality in industrialized nations.
  • Thrombosis is identified as the primary driver of atherosclerosis complications, including myocardial infarction and stroke.
  • Effective treatment for atherothrombosis necessitates a deep understanding of coagulation mechanisms at atherosclerotic lesion sites.

Purpose of the Study:

  • To review the roles of extrinsic and intrinsic blood coagulation pathways in atherosclerotic plaque thrombogenicity.
  • To explore factors influencing the procoagulant/anticoagulant balance in atherosclerosis.

Main Methods:

  • Literature review of studies on blood coagulation and atherosclerosis.
  • Analysis of the contribution of intrinsic and extrinsic pathways to plaque thrombogenicity.

Related Experiment Videos

  • Examination of factors affecting the coagulation balance.

    • Main Results:

    • Both extrinsic and intrinsic coagulation pathways significantly contribute to the thrombogenicity of atherosclerotic plaques.
    • The interplay between procoagulant and anticoagulant factors dictates the overall thrombotic risk.
    • Specific molecular mechanisms within the plaque microenvironment influence this balance.

    Conclusions:

    • A comprehensive understanding of coagulation pathways is essential for managing atherothrombosis.
    • Targeting specific aspects of the coagulation cascade may offer novel therapeutic strategies.
    • Further research into the procoagulant/anticoagulant balance is warranted for improved patient outcomes.